Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Subhasree Kar

MYSTERIOUS: Gilead sciences earnings preview what to expect | Mind Blowing Facts

Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company headquartered in Foster City, California, known for discovering, developing, and commercializing innovative medicines that address serious unmet medical needs in areas such as HIV/AIDS, viral hepatitis, COVID-19, oncology, and inflammation. Gilead Sciences has a market cap of around $155 billion, reflecting its position as a significant player in the healthcare and biotechnology sectors.

The company is set to announce its fiscal Q4 earnings results soon. Ahead of the event, analysts expect GILD to report a profit of $1.86 per share, down 2.1% from $1.90 per share in the year-ago quarter. The company surpassed Wall Street’s bottom-line estimates in three of the past four quarters and missed on another occasion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.